ClinVar Miner

Submissions for variant NM_000518.4(HBB):c.68A>C (p.Glu23Ala) (rs33936254)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000224041 SCV000885559 likely benign not provided 2017-10-11 criteria provided, single submitter clinical testing The Hb G-Coushatta variant (HBB c.68A>C, Glu22Ala) (rs33936254) has been reported in a heterozygous state in multiple individuals (Blackwell 1967, HbVar database and references therein), and exhibits no clinical symptoms when found with a beta0 pathogenic variant (Koseler 2013). It is listed in ClinVar (Variation ID: 15171), and observed twice in the Genome Aggregation Database general population database (2/246046 alleles). The glutamate at residue 22 is highly conserved, but computational algorithms (Align GVGD, PolyPhen-2, SIFT) predict that the variant has no impact on protein structure or function. Based on the above information, the variant is considered likely benign. References: Link to HbVar for Hb G-Coushatta: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=266 Blackwell R et al. Hemoglobin variants in Koreans: hemoglobin G Taegu. Science. 1967; 158(3804):1056-7. Koseler A et al. Molecular studies on the origin of the Hb G-Coushatta mutation in Denizli province of Turkey. Biochem Genet. 2013; 51(1-2):71-5.
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000224041 SCV000281487 pathogenic not provided 2016-05-19 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000030001 SCV000052656 likely benign beta Thalassemia 2015-10-02 no assertion criteria provided clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000224041 SCV000697143 likely benign not provided 2017-01-19 criteria provided, single submitter clinical testing Variant summary: The HBB c.68A>C (p.Glu23Ala, also known as Hb G Coushatta) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a benign outcome for this substitution (SNPs&GO not captured due to low reliability index). This variant was found in 57/546240 control chromosomes at a frequency of 0.0001043, which does not exceed the estimated maximal expected allele frequency of a pathogenic HBB variant (0.0111803). The variant has been found in healthy Native American, Turks, Egyptian, and Sri Lankan in heterozygous or homozygous state indicating neutrality. It was also found to co-occur in cis as well as in trans with beta-thalassemia pathogenic variants (c.93-21G>A, IVS-1-1, G>A, IVS-I-5) in multiple patients, and was believed not to have any clinical impact by authors. Compound heterozygosity of the variant with a pathogenic variant resulted in beta thalasssemia trait. Based on patient phenotype, the variant at most could only be modifier without being causal. A functional study showed the variant to have normal oxygen equilibrium characteristics and heat denaturation and isopropanol tests on hemolysates did not reveal instability of the hemoglobin further supprting neutrality. Considering all evidence, the variant was classified as probably normal.
OMIM RCV000016343 SCV000036611 other HEMOGLOBIN G (COUSHATTA) 2017-12-12 no assertion criteria provided literature only
OMIM RCV000016344 SCV000036612 other HEMOGLOBIN G (SASKATOON) 2017-12-12 no assertion criteria provided literature only
OMIM RCV000016345 SCV000036613 other HEMOGLOBIN G (HSIN-CHU) 2017-12-12 no assertion criteria provided literature only
OMIM RCV000016346 SCV000036614 other HEMOGLOBIN G (TAEGU) 2017-12-12 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.